AlphaCrest Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,416
| Closed | -$222K | – | 878 |
|
|
2022
Q3 | $222K | Sell |
4,416
-4,327
| -49% | -$218K | 0.01% | 1220 |
|
|
2022
Q2 | $350K | Sell |
8,743
-5,747
| -40% | -$230K | 0.02% | 1062 |
|
|
2022
Q1 | $541K | Sell |
14,490
-5,732
| -28% | -$214K | 0.03% | 862 |
|
|
2021
Q4 | $805K | Sell |
20,222
-12,254
| -38% | -$488K | 0.03% | 899 |
|
|
2021
Q3 | $1.21M | Buy |
32,476
+11,790
| +57% | +$439K | 0.06% | 530 |
|
|
2021
Q2 | $874K | Buy |
20,686
+7,989
| +63% | +$338K | 0.04% | 729 |
|
|
2021
Q1 | $601K | Buy |
12,697
+8,806
| +226% | +$417K | 0.03% | 719 |
|
|
2020
Q4 | $237K | Sell |
3,891
-4,213
| -52% | -$257K | 0.02% | 1007 |
|
|
2020
Q3 | $379K | Buy |
8,104
+4,111
| +103% | +$192K | 0.04% | 740 |
|
|
2020
Q2 | $203K | Buy |
+3,993
| New | +$203K | 0.03% | 838 |
|
|
2019
Q4 | – | Sell |
-9,410
| Closed | -$318K | – | 1345 |
|
|
2019
Q3 | $318K | Buy |
+9,410
| New | +$318K | 0.02% | 1086 |
|